(E)-3-(6-((E)-3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridin-2-yl)acrylic acid-D8;ACRIVASTINE-D8;(e)-3-[6-[(e)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid-D8;Acrivastin-D8;(E?E)-3-[6-[1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid-D8;BW-270C-D8;BW-825C-D8;BW-A825C-D8;(E)-3-[6-[(E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]propenoic acid-D8;(E)-3-[6-[(E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridyl]propenoic acid-D8;(E)-6-[(E)-3-(Pyrrolidin-1-yl)-1-(4-methylphenyl)-1-propenyl]-2-pyridinepropenoic acid-D8;Semprex-D8
Acrivastine-d8 is a fully characterized chemical compound used as a reference standard of API Acrivastine. The standard offered is compliant with regulatory guidelines. Acrivastine-d8 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 87848-99-5 (non-labelled)
